GeneDx Holdings Corp (WGS)
28.78
+0.01
(+0.03%)
USD |
NASDAQ |
Jun 14, 16:00
28.80
+0.02
(+0.09%)
After-Hours: 20:00
GeneDx Holdings Cash from Investing (Quarterly): 0.843M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.843M |
| December 31, 2023 | -4.864M |
| September 30, 2023 | -27.13M |
| June 30, 2023 | -11.27M |
| March 31, 2023 | -0.462M |
| December 31, 2022 | -2.838M |
| September 30, 2022 | -4.278M |
| Date | Value |
|---|---|
| June 30, 2022 | -130.30M |
| March 31, 2022 | -3.913M |
| December 31, 2021 | -7.693M |
| September 30, 2021 | -3.618M |
| June 30, 2021 | -4.481M |
| March 31, 2021 | -4.994M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-130.30M
Minimum
Jun 2022
0.843M
Maximum
Mar 2024
-15.77M
Average
-4.481M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| GE HealthCare Technologies Inc | -188.00M |
| Spok Holdings Inc | -0.875M |
| Ontrak Inc | -0.037M |
| DarioHealth Corp | -8.852M |
| FOXO Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.41M |
| Cash from Financing (Quarterly) | -0.438M |
| Free Cash Flow | -146.69M |
| Free Cash Flow Per Share (Quarterly) | -0.6468 |
| Free Cash Flow to Equity (Quarterly) | -15.96M |
| Free Cash Flow to Firm (Quarterly) | -16.26M |
| Free Cash Flow Yield | -19.76% |